Dr. Sigrid Carlsson is Director of Clinical Research at MSK's Josie Robertson Surgery Center and Assistant Attending Epidemiologist in MSK's Departments of Surgery (Urology Service) and Epidemiology and Biostatistics. Her line of research focuses on screening and early detection of prostate cancer, including multiplex testing and risk-stratified strategies that incorporate clinical information, biomarkers and MRI, as recently funded by a NCI U01 award. She also holds an appointment as Associate Professor of Experimental Urology, Gothenburg University, in Sweden where she is an investigator of two large randomized controlled trials of prostate cancer screening (GOTEBORG-1&2), as recently published in the New England Journal of Medicine. She is also an Adjunct Senior Lecturer at Lund University in Sweden. She serves on the NCCN and AUA guidelines for early detection of prostate cancer and was the methodologist for the Prostate Cancer Foundation's guideline on prostate cancer screening for Black men in the US. She recently received the Platinum Award from the European Association of Urology. Her Prevent Cancer Foundation funded research has focused on developing a decision support tool for prostate cancer screening using innovative technology.

Dr. Kelvin A. Moses is the Joseph A. Smith Directorship in Urologic Oncology Chair and Associate Professor of Urology at Vanderbilt University Medical Center. He serves as the Program Director for the Urologic Oncology Fellowship and is the Co-Director of the Comprehensive Prostate Cancer Clinic. Dr. Moses is a Phi Beta Kappa graduate of Morehouse College and received his MD and PhD at Baylor College of Medicine. He completed his Urology training at Emory University and a fellowship in Urologic Oncology at Memorial Sloan-Kettering Cancer Center. His research centers on the impact of health literacy on cancer treatment and outcomes, optimal treatment for patients with advanced renal, testis and penile cancer, and addressing rising cost of care for cancer. 

Brian Bragg is the Chief Mission Officer for ZERO Prostate Cancer.  He has 20 years of progressive leadership experience in the fields of public health and health promotion, with specific expertise in the areas of community and population health, and health systems integration.